Technique rapidly measures cells’ density, reflecting health and developmental state
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
The method could help predict whether immunotherapies will work in a patient or how a tumor will respond to drug treatment.
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
The prestigious fellowship, which honors independence of thought, purposeful leadership, and civic mindset, funds graduate studies at Stanford University.
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
The MESA method uses ecological theory to map cellular diversity and spatial patterns in tissues, offering new insights into disease progression.
The senior, majoring in electrical engineering and computer science, has participated in SuperUROP, NEET, MISTI GTL, and multiple labs focusing on biological EECS.
Scaling up nanoparticle production could help scientists test new cancer treatments.
At an MIT-led event at AJAS/AAAS, researchers connect with MIT faculty, Nobel laureates, and industry leaders to share their work, gain mentorship, and explore future careers in science.
Stefani Spranger is working to discover why some cancers don’t respond to immunotherapy, in hopes of making them more vulnerable to it.
Four professors and an additional alumnus honored with nation’s highest awards for scientists and engineers; Moderna, with deep MIT roots, also recognized.
Five MIT faculty and staff, along with 19 additional alumni, are honored for electrical engineering and computer science advances.
Ten objects on display in the Koch Institute Public Galleries offer uncommon insights into the people and progress of MIT's cancer research community.
The MIT Health and Life Sciences Collaborative will bring together researchers from across the Institute to deliver health care solutions at scale.
MIT chemical engineers designed an environmentally friendly alternative to the microbeads used in some health and beauty products.
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.